Cargando…
Discovery of a Novel Trifluoromethyl Diazirine Inhibitor of SARS-CoV-2 M(pro)
SARS-CoV-2 M(pro) is a chymotrypsin-like cysteine protease playing a relevant role during the replication and infectivity of SARS-CoV-2, the coronavirus responsible for COVID-19. The binding site of M(pro) is characterized by the presence of a catalytic Cys145 which carries out the hydrolytic activi...
Autores principales: | Citarella, Andrea, Moi, Davide, Pedrini, Martina, Pérez-Peña, Helena, Pieraccini, Stefano, Stagno, Claudio, Micale, Nicola, Schirmeister, Tanja, Sibille, Giulia, Gribaudo, Giorgio, Silvani, Alessandra, Passarella, Daniele, Giannini, Clelia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9864213/ https://www.ncbi.nlm.nih.gov/pubmed/36677572 http://dx.doi.org/10.3390/molecules28020514 |
Ejemplares similares
-
Novel Class of Proteasome Inhibitors: In Silico and In Vitro Evaluation of Diverse Chloro(trifluoromethyl)aziridines
por: Ielo, Laura, et al.
Publicado: (2022) -
Synthesis of potent and selective HDAC6 inhibitors led to unexpected opening of a quinazoline ring
por: Moi, Davide, et al.
Publicado: (2022) -
Emerging Applications of Aryl Trifluoromethyl Diazoalkanes
and Diazirines in Synthetic Transformations
por: Ollevier, Thierry, et al.
Publicado: (2022) -
Computational Design, Synthesis, and Biophysical Evaluation of β-Amido Boronic Acids as SARS-CoV-2 M(pro) Inhibitors
por: Fassi, Enrico M. A., et al.
Publicado: (2023) -
Recent Advances in SARS-CoV-2 Main Protease Inhibitors: From Nirmatrelvir to Future Perspectives
por: Citarella, Andrea, et al.
Publicado: (2023)